A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
Condition: Schizophrenia Interventions: Drug: ASP4345; Drug: placebo; Drug: risperidone; Drug: quetiapine; Drug: olanzapine; Drug: ziprasidone; Drug: aripiprazole; Drug: brexpiprazole; Drug: paliperidone; Drug: lurasidone Sponsor: Astellas Pharma Global Development, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Abilify | Geodon | Invega | Risperdal Consta | Schizophrenia | Seroquel | Study | Ziprasidone | Zyprexa